Gastrointestinal adverse events (nausea, diarrhea, constipation) were the most common side effects in Phase 2, consistent with the GLP-1 class
Um, medicine doesn't have it set up that way
17 In STEP 1, waist circumference and blood pressure also were reduced to a significantly greater degree for patients receiving semaglutide than they were for those receiving placebo
If MHRA approval arrives in late 2027 to mid-2028, private availability could begin from late 2027 or 2028, with NHS access from 2029
and avoiding injecting into areas with stretch marks or scars
Ozempic is FDA-approved for the treatment of type 2 diabetes, to improve blood sugar, along with diet and exercise, and reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes and known heart disease, according to the company